CELZ - Creative Medical Technology Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
137.754
88.6
87.754
164.5
165.5
Cost of Revenue
62.24
28.491
47.949
50.596
45.499
Gross Profit
75.514
60.109
39.805
113.904
120.001
Operating Expenses
Research Development
950.635
6,269
109.18
-
0
Selling General and Administrative
4,472
3,944
2,964
1,162
1,223
Total Operating Expenses
5,515
10,304
3,166
1,229
1,250
Operating Income or Loss
-5,439
-10,244
-3,126
-1,115
-1,130
Interest Expense
2,403
0
4,278
1,230
1,896
Total Other Income/Expenses Net
-
-
26,616
-33,981
-5,458
Income Before Tax
-7,804
-10,144
19,212
-36,325
-8,484
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-7,804
-10,144
19,212
-36,325
-8,484
Net Income
-7,804
-10,144
19,212
-36,325
-8,484
Net Income available to common shareholders
-7,804
-10,144
19,212
-36,325
-8,484
Basic EPS
-
-0.93
7.37
-62.69
-410.00
Diluted EPS
-
-0.93
5.61
-62.69
-410.00
Basic Average Shares
-
10,932
2,605
579.461
20.686
Diluted Average Shares
-
10,932
3,249
579.461
20.686
EBITDA
-
-10,052
23,582
-35,029
-6,561